AlphAIAlphAI — Financial news for AI agents
financial-news.co.ukNOV 32 min read$LRCX

LRCX Stock: A 312% Five-Year Run, a 48% Drop From the High, and the Question Nobody Can Quite Answer

Lam Research (LRCX) reported fiscal Q1 revenue of $8.22B, up 54.4% YoY, beating estimates. Despite strong results, the stock fell 5% to $227.56, 48% below its 52-week high. Guidance for Q2 revenue of $8.6B, though lower than expected, and concerns over China exposure and insider selling contributed to the decline. Analysts maintain an average price target of $359, with some bullish calls at $500.

Original reporting
financial-news.co.uk
Published Nov 3, 2026, 11:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
LRCX Stock: A 312% Five-Year Run, a 48% Drop From the High, and the Question Nobody Can Quite Answer — source image
Source · financial-news.co.uk
Decision brief

The 30-second read

$LRCXBearishLow
01

Why it matters

The mixed earnings narrative may keep the stock volatile, with downside bias from guidance and insider sales.

02

Market read

Recap of earnings with modest new commentary; limited trading action.

03

What to watch

Potential upside from upcoming AI server demand and high‑bandwidth memory growth.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

Lam Research reported strong Q1 results but guidance slowdown and China exposure raised concerns.

Company-level read

Ticker impact

$LRCXBearishHigh confidence
Context

The article recaps Lam Research's Q1 earnings and guidance released 13 days earlier, noting slower sequential growth, China exposure, and insider selling.

Expected impact

likely pressure as investors price in weaker guidance and China headwinds

Evidence & confidence

Guidance fell short of expectations and insider sell signals may trigger further selling.

Market effects

Sector

Semiconductor equipment sector may see broader caution due to China exposure concerns.

Regional

Potential modest impact on US tech stocks sensitive to supply‑chain constraints.

Global

Limited; primarily affects Lam Research and peers.

Counterpoint

What could challenge this read

Long‑term AI‑driven wafer demand could still support the stock despite short‑term headwinds.

Key entities

  • Company
    Lam Research

    Semiconductor equipment maker (ticker LRCX).

Read at source← All news

Related articles

OCT 30
$INTCMed

Semiconductor Stocks Fall as Intel Earnings Trigger Broad Tech Selloff

Semiconductor stocks fell after Intel's earnings miss and weak outlook, along with Amazon's earnings shortfall, sparking concerns about AI spending. Intel's stock dropped 25%, erasing $120B in market cap. Broadcom, AMD, Micron, Applied Materials, and Lam Research also declined. Qualcomm fell due to broader tech selloff. Alphabet and Amazon also reported revenue misses, while Meta plans $95B in stock offerings for AI investments.

morningstar.com6 min
OCT 28
$LRCXHigh

Chip Equipment Stocks Rally as SK Hynix Signals Memory Shortage Into 2030: Lam Research Jumps 5%, Applied Materials Climbs 4%, KLA Gains 3%

SK Hynix (SKHY) predicts a memory shortage until 2030, driving gains in chip equipment stocks. Lam Research (LRCX) rose 5%, Applied Materials (AMAT) 4%, and KLA (KLAC) 3%. SK Hynix's outlook suggests increased demand for fab equipment. Lam Research faces supply constraints, forecasting $8.6B in Q4 revenue. Applied Materials and KLA also reported growth. ASML (ASML) gained 1%.

247wallst.com3 min
OCT 28
$LRCXHighAI 8/10

Why is Lam Research stock rallying today?

Lam Research (LRCX) stock rose 3.4% after SK Hynix reported record Q3 2026 revenue and strong demand for memory chips. Analyst Lynx Equity reiterated a $400 price target, citing robust sector demand and potential share buybacks. The rally was driven by company-specific factors, not broader market trends.

investing.com1 min
OCT 27
$LRCXMed

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

finance.yahoo.com3 min
OCT 27
$LRCXMedAI 8/10

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

finance.yahoo.com3 min
OCT 26
$LRCXMed

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

finance.yahoo.com2 min